EyeWorld Asia-Pacific June 2016 Issue

June 2016 56 EWAP CORNEA While all the physicians interviewed said complications from the inlay procedure and the device itself are rare, some of the most common problems include decentration of the inlay, dry eye, and neuroadaptation issues. The inlays could also cause halo or glare in some patients. “Time, reassurance, and adaptation would help with that. But I suppose there are patients who may never tolerate it, and the inlay may need to be removed. I have not had to remove any yet,” Dr. Wiley said. The beauty of the inlay is that it can be easily removed with the patient’s vision reverting back to where it was at the time of the original surgery, Dr. Hovanesian said. As for how the inlays compare to other presbyopia-correcting procedures, Dr. Wiley said that an inlay like the KAMRA would continue to perform as a patient’s vision ages, while LASIK with monovision, for instance, “is a one-time situation that only has a certain range of correction.” A multifocal IOL has similar pros and cons to inlays, Dr. Wiley said. While IOLs would also function well over time as a patient ages, they might not be the best option for patients who don’t tolerate multifocal vision well. The opportunity Dr. Wiley said inlays present an opportunity not just for patients who have presbyopia now, but for those who haven’t developed it yet. According to the “Global Presbyopia-Correcting Surgery Market Report,” more than 2 billion people worldwide will be presbyopic by 2020, making it an almost inevitable condition for all adults at some point in their 40s and beyond. 2 “If you look at the aging process, right now if a 30-somethingyear-old comes in with nearsightedness and wants to have LASIK, they’ll say ‘Great, but should I really get LASIK CALENDAR OF MEETINGS 2016 DATE MEETING VENUE June 24-26 31st Annual Meeting of the Japanese Society of Cataract & Refractive Surgery (JSCRS) www.jscrs.org Kyoto Japan July 27-30 29th Asia-Paci c Association of Cataract and Refractive Surgeons Annual Meeting (APACRS) www.apacrs.org Bali Indonesia September 10-14 XXXIV Congress of European Society of Cataract and Refractive Surgery (ESCRS) www.escrs.org Copenhagen Denmark October 15-18 Annual Meeting of American Academy of Ophthalmology (AAO) www.aao.org Chicago USA because in 10 years I’m going to need glasses anyway?’” Dr. Wiley said. “Now we can say we have a solution for that, you can either do monovision or you can do a corneal inlay; we now have things that can be added onto LASIK that can extend the life [of that vision] without needing glasses.” Dr. Wiley thinks that the advent of inlays will give younger patients the confidence they need to decide to invest in LASIK, knowing that they won’t necessarily be limited by glasses again in the future. For the patient who has already invested in LASIK, this procedure could give them continued independence from glasses. “They say that technology reaches its peak when it becomes invisible, and inlays are an invisible technology that rests in the eye and gives an ability that you would otherwise have lost with age,” Dr. Hovanesian said, adding that he thinks “surgeons who are serious about laser correction should learn more about [inlays and] should offer this technology so they’re providing a complete spectrum of care. You can’t be a full-service LASIK surgeon and not offer inlays.” EWAP References 1. Seyeddain O, et al. Small-aperture corneal inlay for the correction of presbyopia: 3-year follow-up. J Cataract Refract Surg . 2012;38:35–45. 2. Market Scope. Global Presbyopia- Correcting Surgery Market Report. 2012. Editors’ note: Dr. Hovanesian has financial interests with ReVision Optics, Alcon (Fort Worth, Texas), and Abbott Medical Optics (Abbott Park, Ill.). Dr. Lindstrom has financial interests with AcuFocus, Alcon, Abbott Medical Optics, and Bausch + Lomb (Bridgewater, NJ). Dr. Wiley has financial interests with AcuFocus, Presbia, ReVision Optics, Abbott Medical Optics, and Alcon. Contact information Hovanesian: johnhova@gmail.com Lindstrom: rllindstrom@mneye.com Wiley: drwiley@clevelandeyeclinic.com The ins - from page 55